Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Haruka Maehashi"'
Autor:
Jonghyuk Park, Takahiro Masaki, Yoshihiro Mezaki, Hiroshi Yokoyama, Mariko Nakamura, Haruka Maehashi, Takahiko J Fujimi, Sabine S Gouraud, Keisuke Nagatsuma, Madoka Nakagomi, Naofumi Kimura, Tomokazu Matsuura
Publikováno v:
PLoS ONE, Vol 12, Iss 12, p e0189346 (2017)
We developed a bio-artificial liver (BAL) using a radial-flow bioreactor and rescued mini-pig models with lethal acute liver failure (ALF). The point of the rescue is the recovery from hepatic encephalopathy (HE). HE on ALF has sometimes resulted in
Externí odkaz:
https://doaj.org/article/b6537d1327ff4c668cb7a53d8a4d32d7
Autor:
Tomokazu Matsuura, Mariko Nakamura, Misako Shirai, Kiyoshi Ohkawa, Kiyotsugu Yoshida, Hideki Nomoto, Takahiro Masaki, Yoshihiro Mezaki, Jonghyuk Park, Haruka Maehashi, Mamoru Aizawa
Publikováno v:
Human Cell
Bone grafting is necessary before dental implant treatment in patients with jaw bone defects. Currently, autologous bone grafting is a major burden on the patient. However, it is impossible to form a sufficient foundation for the implant with a bone-
Autor:
Tomokazu, Matsuura, Yoshihiro, Mezaki, Takahiro, Masaki, Yoshihiro, Matsumoto, Haruka, Maehashi, Mariko, Nakamura, Koji, Nakada, Jong Hyuk, Park, Hiroshi, Yokoyama
Publikováno v:
Rinsho byori. The Japanese journal of clinical pathology. 64(5)
The urea breath test was developed for the diagnosis of Helicobacter pylori infection. In this test, we measure exhaled ¹³CO₂ using POCone developed in Japan, which is an infrared spectrometry photometer. Based on the urea breath test, we subsequ
Autor:
Takahiro Masaki, Keisuke Nagatsuma, Yoshihiro Mezaki, Naofumi Kimura, Madoka Nakagomi, Tomokazu Matsuura, Mariko Nakamura, Hiroshi Yokoyama, Sabine S. Gouraud, Jonghyuk Park, Takahiko J. Fujimi, Haruka Maehashi
Publikováno v:
PLoS ONE, Vol 12, Iss 12, p e0189346 (2017)
PLoS ONE
PLoS ONE
Background and aims We developed a bio-artificial liver (BAL) using a radial-flow bioreactor and rescued mini-pig models with lethal acute liver failure (ALF). The point of the rescue is the recovery from hepatic encephalopathy (HE). HE on ALF has so
Autor:
Koji Takada, Katsuhiko Yanaga, Katsuhiko Aoki, Takeo Iwamoto, Tomokazu Matsuura, Haruka Maehashi, Kiyoshi Ohkawa, Kiyotsugu Yoshida, Michinori Matsumoto
Publikováno v:
Hepatology Research. 45:315-325
Aim Despite an increasing demand, blood products are not always safe because most are derived from blood donations. One possible solution is the development and commercialization of recombinant fibrinogen, but this process remains poorly developed. T
Autor:
Toshifumi Ohkusa, Hiroshi Hano, Tomokazu Matsuura, Keisuke Nagatsuma, Kazuhiro Murakami, Ichiro Takagi, Daisuke Shindo, Masaya Saito, Masahiro Ikegami, Yoshihiro Matsumoto, Jimi Mitobe, Ken Tanaka, Akihito Tsubota, Yoshio Aizawa, Hisao Tajiri, Mamiko Owada, Haruka Maehashi
Publikováno v:
Liver International. 34:243-252
Background & Aims Precisely what type of cells mainly contributes to portal fibrosis, especially in chronic viral hepatitis, such as hepatic stellate cells (HSCs) in the parenchyma or myofibroblasts in the portal area, still remains unclear. It is ne
Autor:
Tomokazu Matsuura, Maiko Miura, Jun Fukasawa, Mamoru Aizawa, Yumiko Yasutomi, Haruka Maehashi
Publikováno v:
Key Engineering Materials. :397-401
We have successfully developed porous apatite-fiber scaffolds (AFSs) which have three-dimensional (3D) inter-connected pores; subsequently, we have clarified that the AFSs have an excellent bioactivity on the basis of both in vitro and in vivo evalua
Publikováno v:
Key Engineering Materials. :402-406
We have successfully developed the apatite-fiber scaffold (AFS) with enhanced mechanical porosity for tissue engineering of bone and liver via two routes: i) use of two type of carbon beads with diameter of ~150 μm and ~20 μm and following ii) unia
Autor:
Jun Fukasawa, Haruka Maehashi, Tomokazu Matsuura, Mamoru Aizawa, Maiko Miura, Yumiko Yasutomi
Publikováno v:
Key Engineering Materials. :878-883
Tissue engineering has been studied as a novel therapeutic technology which replaces organ transplantation. Tissue engineering consists of three factors “scaffolds”, “cells” and “growth factors”, and regenerates defecting tissue using the
Autor:
Ryusuke Ito, Ryota Saito, Keisuke Nagatsuma, Tomokazu Matsuura, Hiroshi Mano, Ken Tanaka, Mamoru Aizawa, Haruka Maehashi, Hideki Nomoto, Kiyoshi Ohkawa, Yuji Ishii, Hiroshi Hano, Masaya Saito, Katsuhiko Yanaga
Publikováno v:
Artificial Organs. 35:80-83
Liver organoids were reconstructed by mouse-immortalized hepatocytes and nonparenchymal cells (sinusoidal endothelial cells and hepatic stellate cells) in a radial-flow bioreactor (RFB). A biodegradable apatite-fiber scaffold (AFS) was used as a scaf